Andrew Serafin's Insider Trades & SAST Disclosures
Andrew Serafin's most recent trade in Harmony Biosciences Holdings Inc was a trade of 36,500 Stock Option done . Disclosure was reported to the exchange on Jan. 24, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Andrew Serafin.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Harmony Biosciences Holdin... | Andrew Serafin | CHIEF STRATEGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 36,500 | 36,500 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Andrew Serafin | CHIEF STRATEGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2025 | 10,400 | 10,400 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdin... | Andrew Serafin | CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 2,500 | 2,500 | - | 0 | Common Stock | |
| Harmony Biosciences Holdin... | Andrew Serafin | CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Jan 2025 | 2,500 | 7,500 | - | - | Restricted Stock Units | |
| Harmony Biosciences Holdin... | Andrew Serafin | CHIEF STRATEGY OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 38.01 per share. | 24 Jan 2025 | 865 | 1,635 | - | 38.0 | 32,879 | Common Stock |
| Harmony Biosciences Holdin... | Serafin Andrew | CHIEF STRATEGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 47,750 | 47,750 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Serafin Andrew | CHIEF STRATEGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jan 2024 | 10,000 | 10,000 | - | - | Restricted Stock Unit | |
| Harmony Biosciences Holdin... | Andrew Serafin | CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2022 | 38,000 | 83,729 | - | - | Stock Option | |
| Harmony Biosciences Holdin... | Andrew Serafin | CHIEF STRATEGY OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.22 per share. | 02 Dec 2022 | 38,000 | 38,000 | - | 8.2 | 312,360 | Common Stock |
| Harmony Biosciences Holdin... | Andrew Serafin | CHIEF STRATEGY OFFICER | Sale of securities on an exchange or to another person at price $ 60.12 per share. | 02 Dec 2022 | 37,080 | 920 | - | 60.1 | 2,229,246 | Common Stock |
| Harmony Biosciences Holdin... | Andrew Serafin | CHIEF STRATEGY OFFICER | Sale of securities on an exchange or to another person at price $ 60.71 per share. | 02 Dec 2022 | 920 | 0 | - | 60.7 | 55,854 | Common Stock |
| Harmony Biosciences Holdin... | Andrew Serafin | Chief Business Officer | 21 Aug 2020 | 200,000 | 0 | - | - | Series A Preferred Stock | ||
| Harmony Biosciences Holdin... | Andrew Serafin | Chief Business Officer | 21 Aug 2020 | 51,021 | 0 | - | - | Series C Preferred Stock | ||
| Harmony Biosciences Holdin... | Andrew Serafin | Chief Business Officer | 21 Aug 2020 | 33,693 | 33,693 | - | - | Common Stock | ||
| Harmony Biosciences Holdin... | Andrew Serafin | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2020 | 81,875 | 81,875 | - | - | Stock Option |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges